Synaptic mechanism for functional synergism between δ- And μ-opioid receptors

Journal of Neuroscience

Volumn 30, Issue 13, 2010, Pages 4735-4745

  Zhang, Zhi ^a   Pan, Zhizhong Z ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; OPIATE; PHOSPHOLIPASE A2;

4 AMINOBUTYRIC ACID RELEASE; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; GABAERGIC TRANSMISSION; INHIBITORY POSTSYNAPTIC POTENTIAL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RAPHE MAGNUS NUCLEUS; RAT; SYNAPTIC TRANSMISSION; UPREGULATION;

ANALGESICS, OPIOID; ANIMALS; BRAIN STEM; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DRUG SYNERGISM; GAMMA-AMINOBUTYRIC ACID; INHIBITORY POSTSYNAPTIC POTENTIALS; MORPHINE; PATCH-CLAMP TECHNIQUES; PHOSPHOLIPASES A2; PRESYNAPTIC TERMINALS; RATS; RATS, WISTAR; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; SIGNAL TRANSDUCTION; SYNAPSES; UP-REGULATION;

EID: 77950663512     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5968-09.2010     Document Type: Article

References (47)

1. Adams JU, Talkrida RJ, Geller EB, Adler MW (1993) Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used. J Pharmacol Exp Ther 266:1261-1267.
2. Ballantyne JC, LaForge KS (2007) Opioid dependence and addiction during opioid treatment of chronic pain. Pain. 129:235-255. (Pubitemid 46754581)
3. Bhargava HN (1994) Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior. Pharmacol Rev 46:293-324.
4. Bie B, Pan ZZ (2003) Presynaptic mechanism for anti-analgesic and antihyperalgesic actions of κ-opioid receptors. J Neurosci 23:7262-7268. (Pubitemid 36999515)
5. Bie B, Peng Y, Zhang Y, Pan ZZ (2005) cAMP-mediated mechanisms for pain sensitization during opioid withdrawal. J Neurosci 25:3824-3832. (Pubitemid 40570415)
6. Bie B, ZhuW, Pan ZZ (2009) Rewarding morphine-induced synaptic function of delta-opioid receptors on central glutamate synapses. J Pharmacol Exp Ther 329:290-296.
7. Bolan EA, Tallarida RJ, Pasternak GW (2002) Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes. J Pharmacol Exp Ther 303:557-562.
8. Cahill CM, Morinville A, Lee MC, Vincent JP, Collier B, Beaudet A (2001) Prolonged morphine treatment targets δ opioid receptors to neuronal plasma membranes and enhances δ-mediated antinociception. J Neurosci 21:7598-7607. (Pubitemid 32904959)
9. Cahill CM, Holdridge SV, Morinville A (2007) Trafficking of delta-opioid receptors and other G-protein-coupled receptors: implications for pain and analgesia. Trends Pharmacol Sci 28:23-31.
10. Chieng B, Williams JT (1998) Increased opioid inhibition of GABA release in nucleus accumbens during morphine withdrawal. J Neurosci 18:7033-7039. (Pubitemid 28388032)
11. Clark MJ, Furman CA, Gilson TD, Traynor JR (2006) Comparison of the relative efficacy and potency of mu-opioid agonists to activate Galpha(i/o) proteins containing a pertussis toxin-insensitive mutation. J Pharmacol Exp Ther 317:858-864.
12. Commons KG (2003) Translocation of presynaptic delta opioid receptors in the ventrolateral periaqueductal gray after swim stress. J Comp Neurol 464:197-207.
13. Contet C, Kieffer BL, Befort K (2004) Mu opioid receptor: a gateway to drug addiction. Curr Opin Neurobiol 14:370-378. (Pubitemid 38759868)
14. Fields H (2004) State-dependent opioid control of pain. Nat Rev Neurosci 5:565-575.
15. Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA (2004) A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci U S A 101:5135-5139. (Pubitemid 38469214)
16. Hack SP, Bagley EE, Chieng BC, Christie MJ (2005) Induction of δ-opioid receptor function in the midbrain after chronic morphine treatment. J Neurosci 25:3192-3198.
17. Højsted J, Sjøgren P (2007) Addiction to opioids in chronic pain patients: a literature review. Eur J Pain 11:490-518. (Pubitemid 46670780)
18. Horan P, Tallarida RJ, Haaseth RC, Matsunaga TO, Hruby VJ, Porreca F (1992) Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: supra- and sub-additivity. Life Sci 50:1535-1541.
19. Hurley RW, Hammond DL (2000) The analgesic effects of supraspinal, μ and δ opioid receptor agonists are potentiated during persistent inflammation. J Neurosci 20:1249-1259.
20. Hurley RW, Grabow TS, Tallarida RJ, Hammond DL (1999) Interaction between medullary and spinal delta1 and delta2 opioid receptors in the production of antinociception in the rat. J Pharmacol Exp Ther 289:993-999.
21. Ingram SL, Vaughan CW, Bagley EE, Connor M, Christie MJ (1998) Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. J Neurosci 18:10269-10276. (Pubitemid 29016546)
22. Inturrisi CE (2002) Clinical pharmacology of opioids for pain. Clin J Pain 18:S3-S13.
23. Ma J, Pan ZZ (2006) Contribution of brainstem GABA(A) synaptic transmission to morphine analgesic tolerance. Pain 122:163-173.
24. Ma J, Zhang Y, Kalyuzhny AE, Pan ZZ (2006) Emergence of functional delta-opioid receptors induced by long-term treatment with, morphine. Mol Pharmacol 69:1137-1145.
25. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dollé P, Tzavara E, Hanoune J, Roques BP, Kieffer BL (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383:819-823. (Pubitemid 26372664)
26. Murakami M, Kudo I (2002) Phospholipase A2. J Biochem 131:285-292. Negus SS, Bear AE, Folk JE, Rice KC (2009) Role of delta opioid efficacy as a determinant of mu/delta opioid interactions in rhesus monkeys. Eur J Pharmacol 602:92-100.
27. Nestler EJ (2004) Historical review: Molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol Sci 25:210-218.
28. Pan ZZ (1998) mu-Opposing actions of the kappa-opioid receptor. Trends Pharmacol Sci 19:94-98.
29. Pan ZZ (2003) Opioid tolerance in adult and neonatal rats. Methods Mol Med 84:223-232.
30. Pan ZZ, Williams JT, Osborne PB (1990) Opioid actions on single nucleus raphe magnus neurons from rat and guinea-pig in vitro. J Physiol 427: 519-532.
31. Pan ZZ, Tershner SA, Fields HL (1997) Cellular mechanism for antianalgesic action of agonists of the kappa-opioid receptor. Nature 389: 382-385.
32. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, Ed 2. Sydney: Academic.
33. Quock RM, Burkey TH, Varga E, Hosohata Y, Hosohata K, Cowell SM, Slate CA, Ehlert FJ, Roeske WR, Yamamura HI (1999) The delta-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy. Pharmacol Rev 51:503-532. (Pubitemid 29420213)
34. Reynolds LJ, Hughes LL, Yu L, Dennis EA (1994) 1-Hexadecyl-2- arachidonoylthio-2-deoxy-sn-glycero-3-phosphorylcholine as a substrate for the microtiterplate assay of human cytosolic phospholipase A2. Anal Biochem 217:25-32. (Pubitemid 2034133)
35. Robinson-White A, Stratakis CA (2002) Protein kinase A signaling: "crosstalk" with other pathways in endocrine cells. Ann NY Acad Sci 968: 256-270.
36. Rossi GC, Pasternak GW, Bodnar RJ (1994) Mu and delta opioid synergy between the periaqueductal gray and the rostro-ventral medulla. Brain Res 665:85-93.
37. Sharma SK, Klee WA, Nirenberg M. (1975) Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc Natl Acad Sci U S A 72:3092-3096.
38. Stevenson GW, Folk JE, Rice KC, Negus SS (2005) Interactions between delta and mu opioid agonists in assays of schedule-controlled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys: studies with SNC80 [( + )-4-[(alphaR)-alpha((2S,5R)-4-allyl-2,5- dimethyl-l-piperazinyl)-3-methoxybenzyl]-N,Ndiethylbenzami.de] and heroin. J Pharmacol Exp Ther 314:221-231.
39. Sykes KT, White SR, Hurley RW, Mizoguchi H, Tseng LF, Hammond DL (2007) Mechanisms responsible for the enhanced antinociceptive effects of micro-opioid receptor agonists in the rostral ventromedial medulla of male rats with persistent inflammatory pain. J Pharmacol Exp Ther 322: 813-821. (Pubitemid 47105822)
40. Tallarida RJ (2006) An overview of drug combination analysis with isobolograms. J Pharmacol Exp Ther 319:1-7.
41. Vaughan CW, Ingram SL, Connor MA, Christie MJ (1997) How opioids inhibit GABA-mediated neurotransmission. Nature 390:611-614.
42. Waldhoer M, Bartlett SE, Whistler JL (2004) Opioid receptors. Annu Rev Biochem 73:953-990.
43. Williams JT, Christie MJ, Manzoni O (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81:299-343.
44. Woolf CJ, Hashmi M (2004) Use and abuse of opioid analgesics: potential methods to prevent and deter non-medical consumption of prescription opioids. Curr Opin Investig Drugs 5:61-66.
45. Zhang X, Bao L, Guan JS (2006) Role of delivery and trafficking of deltaopioid peptide receptors in opioid analgesia and tolerance. Trends Pharmacol Sci 27:324-329. (Pubitemid 44183608)
46. Zhu W, Pan ZZ (2005) M.u-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons. Neuroscience 133: 97-103. (Pubitemid 40694161)
47. Zucker RS, Regehr WG (2002) Short-term synaptic plasticity. Annu Rev Physiol 64:355-405.